Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Apollo Munich...

    Apollo Munich Insurance to put in Rs. 50 crore for business expansion

    Written by Geeta Sharma Sharma Published On 2016-08-08T12:40:40+05:30  |  Updated On 8 Aug 2016 12:40 PM IST
    Apollo Munich Insurance to put in Rs. 50 crore for business expansion
    New Delhi: Apollo Munich Health Insurance has announced its decision to put in another Rs.50 crore capital in the last quarter of the current fiscal year for business expansion.

    The decision comes in the face of a requirement emerging towards the end of the year, though the insurance company is adequately financially furnished for the moment, said CEO Antony Jacob .

    Having grown 27% last fiscal, Apollo Munich stands at a current paid up capital of Rs. 357 crore; expecting a 30% increase in new business for 2016-17. According to Jacob, Apollo Munich Health Insurance intends achieving a gross written premium (GWP) of Rs.1300 crore, ending March 2017.

    The company’s ampower application, a paperless initiative to underwrite policy is another tool which is expected to boost the company's current financial growth by 65-75 percent, stated the CEO.

    "Ampower app has enabled our sales force to issue a policy in 7 minutes from the traditional 14 days period," he added.

    15000 agents are expected to be using the Ampower application by the end of the current financial year. With this Apollo Munich Health Insurance will have achieved the baseline required to measure productivity.

    The Apollo Hospitals group has taken a stride further by selling 23.3 per cent shareholding in Apollo Munich Health Insurance Company to its German partner Munich Re for Rs 163.5 crore.

    Ampower applicationAntony JacobApollo Munich Health InsuranceCEOGWPinsuranceMunich Re
    Source : with inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Geeta Sharma Sharma
    Geeta Sharma Sharma
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok